Dr. Reddy’s Laboratories Limited | 12/12/2025 | 483
Similar Posts
Clinical Outcome Assessment (COA) Qualification Program: Frequently Asked Questions
CDER Clinical Outcome Assessments (COA) Qualification Program: Frequently Asked Questions (FAQs)Ideal Specialty Apothecary Inc., dba Ideal Pharmacy, Union, NJ. 483 Issued 08/31/2017
Ideal Specialty Apothecary Inc., dba Ideal Pharmacy, Union, NJ. 483 Issued 08/31/2017Task Description Request Please post to the 2017 Pharmacy Inspections and Related Records Web page
Record Date 08/31/2017
FEI Number 3013505558
Firm Name Ideal Specialty Apothecary Inc., dba Ideal Pharmacy
RecordGepotidacin – Oral Products
Gepotidacin – Oral ProductsGeneric Drug Facilities, Sites and Organization Lists
Generic Drug Facilities, Sites and Organization ListsFDA approves taletrectinib for ROS1-positive non-small cell lung cancer
On June 11, 2025, the Food and Drug Administration approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).IBSPOT.com Inc. – 715657 – 10/27/2025
Unapproved New Drugs/Misbranded